pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
CYCLE · news · pharmadog
← back to CYCLE
News mentioning CYCLE
66
stories
54m
Rare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meeting
biospace
5d
Merck adds 53 to New Jersey chopping block
biospace
7d
Opinion: It’s time to take the gloves off during vaccination
stat
7d
STAT+: UnitedHealth executives shower high-ranking Democrat with donations ahead of midterms
stat
7d
Inhibrx CEO says progression-free survival data leave ‘no question’ about OX40 agonist’s durability
fiercebiotech
12d
Biopharma needs more data scientists. Who's getting hired?
biospace
13d
Follow the money: How funding announcements can help identify jobs before they’re posted
biospace
13d
UniQure files for FDA, UK approval of first gene therapy for Huntington’s disease
biospace
13d
Opinion: The next DSM should address the algorithm’s role in eating disorders
stat
13d
Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial fails
biospace
13d
Opinion: I’m a reproductive psychiatrist. The Lindsay Clancy trial will cause terrible damage to my field
stat
13d
Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
fiercebiotech
14d
STAT+: Will House delay Trump plan to politicize NIH grants?
stat
15d
Takeda, Protagonist score broad FDA nod in rare blood cancer, setting up $2B opportunity
biospace
19d
Hospitals are plotting a long-shot push to roll back $1 trillion in Medicaid cuts
stat
21d
Biotech IPOs approach ‘escape velocity’ barring yellow flags that could threaten rebound
biospace
26d
Opinion: The global health aid architecture is collapsing. The faith economy isn’t
stat
27d
STAT+: Nonprofit health system raked in $1.1 billion this year from stake in medical billing firm
stat
29d
FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vax
biopharma dive
Aug 14, 26
BMS welcomes new multiple myeloma drug as generics batter current portfolio
biospace
Aug 13, 26
PDUFA VIII: FDA outlines goals, program enhancements in commitment letter
raps
Aug 12, 26
With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development
biospace
Aug 11, 26
Building Resilience for the Future of Biopharma Innovation
fiercebiotech
Aug 10, 26
Regulatory operations: The overlooked half of submission readiness
biopharma dive
Aug 7, 26
Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attack
stat
Aug 6, 26
STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and more
stat
Aug 5, 26
4 potential biotech M&A targets, plus a pretty sure bet from J&J
biospace
Aug 4, 26
Opinion: I’m using not-FDA-approved software to manage my diabetes. I’ve never felt better
stat
Jul 30, 26
J&J pays Sail $785M, charting course to possible in vivo CAR-T buyout
fiercebiotech
Jul 30, 26
Recon: FDA adcomm votes against Capricor’s DMD drug; Cytokinetics gets UK approval, NICE backing for heart drug
raps
← prev
page 1 of 3
next →
